RLBAX
Price
$36.59
Change
-$0.20 (-0.54%)
Updated
Aug 5 closing price
Net Assets
253.92B
SIBLX
Price
$29.40
Change
-$0.06 (-0.20%)
Updated
Aug 5 closing price
Net Assets
975.8M
Interact to see
Advertisement

RLBAX vs SIBLX

Header iconRLBAX vs SIBLX Comparison
Open Charts RLBAX vs SIBLXBanner chart's image
American Funds American Balanced R1
Price$36.59
Change-$0.20 (-0.54%)
VolumeN/A
Net Assets253.92B
Touchstone Balanced Y
Price$29.40
Change-$0.06 (-0.20%)
VolumeN/A
Net Assets975.8M
RLBAX vs SIBLX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RLBAX vs. SIBLX commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLBAX is a Buy and SIBLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBAX has more cash in the bank: 254B vs. SIBLX (976M). SIBLX pays higher dividends than RLBAX: SIBLX (1.59) vs RLBAX (1.17). RLBAX was incepted earlier than SIBLX: RLBAX (23 years) vs SIBLX (18 years). RLBAX (1.31) is less costly to investors than SIBLX (0.79). SIBLX is a more actively managed with annual turnover of: 70.00 vs. RLBAX (44.00). RLBAX has a lower initial minimum investment than SIBLX: RLBAX (250) vs SIBLX (2500). SIBLX annual gain was more profitable for investors over the last year : 14.56 vs. RLBAX (10.13). SIBLX return over 5 years is better than : 36.08 vs. RLBAX (32.30).
RLBAXSIBLXRLBAX / SIBLX
Total Expense Ratio1.310.79166%
Annual Report Gross Expense Ratio1.310.79166%
Fund Existence23 years18 years-
Gain YTD7.8587.443106%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets254B976M26,025%
Annual Yield % from dividends1.171.5974%
Returns for 1 year10.1314.5670%
Returns for 3 years28.3436.1378%
Returns for 5 years32.3036.0890%
Returns for 10 years57.4271.0881%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APRE1.790.09
+5.29%
Aprea Therapeutics
FATE1.080.02
+1.89%
Fate Therapeutics
SYF69.991.04
+1.51%
Synchrony Financial
TCBI81.340.03
+0.04%
Texas Capital Bancshares
FCBC35.950.01
+0.03%
First Community Bankshares